![]() The proportion of patients who are up to date with documented pneumococcal vaccination was suboptimal in our rheumatology practice. Patients treated by rheumatologists in practice for ≤10 years were more likely to be up to date with pneumococcal vaccination (72%) than those with providers in practice >10 years (52%, P < 0.001).Ĭonclusion. Among new initiators of immunosuppressive medications, 258/568 (45%) were vaccinated before starting the immunosuppressive medication. Of patients on immunosuppressive medications, 1491/2763 (54%) were up to date with pneumococcal vaccination. The most frequent disease was RA (50%) and the most common immunosuppressive medication was MTX (59%). The mean age was 57 years, 75% were female and 77% were Caucasian. We identified 2763 rheumatology clinic patients on immunosuppressive medications, with 568 initiated in the last 12 months. We calculated the proportion of eligible patients who were up-to-date with pneumococcal vaccination: (i) while on an immunosuppressive medication and (ii) before newly starting an immunosuppressive medication in the last 12 months. CDC recommendations for pneumococcal vaccination were applied. Using data from administrative (billing) and electronic health record sources, we identified rheumatology clinic patients seen between 1 February 2008 and 31 January 2010 and prescribed an immunosuppressive medication. To support continuous quality improvement efforts, we electronically measured vaccination status among rheumatology outpatients over time. Data suggest that rates of vaccination in this population are not optimal. ![]() The Centers for Disease Control (CDC) recommends pneumococcal vaccination for immunocompromised patients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |